The most effective polymorphisms of paraoxonase-1 gene on enzyme activity and concentration of paraoxonase-1 protein in type 2 diabetes mellitus patients and non-diabetic individuals: A systematic review and meta-analysis
- PMID: 31102685
- DOI: 10.1016/j.diabres.2019.05.007
The most effective polymorphisms of paraoxonase-1 gene on enzyme activity and concentration of paraoxonase-1 protein in type 2 diabetes mellitus patients and non-diabetic individuals: A systematic review and meta-analysis
Abstract
Introduction: Many studies have evaluated the association of paraoxonase-1 (PON1) gene polymorphisms with enzyme activity and concentration in type 2 diabetes mellitus (T2DM). However, the exact impact of these polymorphisms is not still obvious. Hence, we conducted a systematic review and meta-analysis to clarify the association of PON1 polymorphisms with its enzyme characteristics in T2DM patients and non-diabetic individuals.
Methods: We searched electronic databases including PubMed, Web of Science, Embase and Scopus for publications by April 2018. The pooled response ratio (rr) for the association and their corresponding 95% confidence intervals (CIs) were calculated using a fixed-effect model.
Results: Fifteen relevant studies fulfilled our inclusion criteria. The results showed a 1.25-fold increase in total PON1 activity in non-diabetic group against T2DM patients (p-value = 0.024). Also, only Q192R and L55M polymorphisms had sufficient studies to be included in the meta-analysis. All three genotypes of Q192R polymorphism showed significantly different activities between the study groups with the highest pooled effect size for RR genotype (rrQQ < rrQR < rrRR) while this difference was seen only in LL genotype of L55M polymorphism. Therefore, Q192R polymorphism was more correlated with type 2 diabetes mellitus. In case of concentration, there was no significant differences between two groups (p-value = 0.897).
Conclusion: Current meta-analysis suggested that the observed difference of total PON1 activity was due to the different activity of various genotypes of PON1 enzyme in case of L55M and Q192R polymorphisms so that LL and RR genotypes had the most important role in the establishment of mentioned difference.
Keywords: Enzyme activity; Enzyme concentration; Paraoxonase-1; Polymorphism; Type 2 diabetes mellitus.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Paraoxonase 1 (PON1) L55M and Q192R polymorphisms are not associated with chronic kidney disease in Thai individuals with type 2 diabetes.Int J Clin Pract. 2021 Dec;75(12):e14982. doi: 10.1111/ijcp.14982. Epub 2021 Oct 20. Int J Clin Pract. 2021. PMID: 34637171
-
Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.Gene. 2011 Nov 1;487(1):88-95. doi: 10.1016/j.gene.2011.07.011. Epub 2011 Jul 26. Gene. 2011. PMID: 21803130
-
European versus Asian differences for the associations between paraoxonase-1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus.J Cell Mol Med. 2018 Mar;22(3):1720-1732. doi: 10.1111/jcmm.13453. Epub 2018 Jan 4. J Cell Mol Med. 2018. PMID: 29314660 Free PMC article.
-
Paraoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity: A meta-analysis.Z Gerontol Geriatr. 2016 Jan;49(1):24-31. doi: 10.1007/s00391-015-0892-1. Epub 2015 May 12. Z Gerontol Geriatr. 2016. PMID: 25962362 Review.
-
PON1 Q192R and L55M polymorphisms and organophosphate toxicity risk: a meta-analysis.DNA Cell Biol. 2013 May;32(5):252-9. doi: 10.1089/dna.2012.1961. Epub 2013 Apr 16. DNA Cell Biol. 2013. PMID: 23590198 Review.
Cited by
-
Paraoxonase 1 and atherosclerosis.Front Cardiovasc Med. 2023 Feb 16;10:1065967. doi: 10.3389/fcvm.2023.1065967. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36873390 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous